Trade Mark Journal No.2021/053 31 December 2021
WO0000001630185 (5)
Office of origin: United States of America
Date of International Registration:2 November 2021
Date of designation in the UK:
2 November 2021

International priority date claimed: 5 May 2021
(United States of America)
(90690878)
- Class 5
- Pharmaceutical formulations and compositions containing topiramate; pharmaceutical preparations for the preventative treatment of seizures or migraines; anticonvulsants.
Azurity Pharmaceuticals, Inc.
Representative: Douglas R. Wolf Wolf, Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston MA 02210, UNITED STATES OF AMERICA